| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/31/2006 | WO2006091246A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/31/2006 | WO2006090285A1 Ocaperidone salts and pharmaceutical compositions containing the same |
| 08/31/2006 | WO2006090273A2 [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia |
| 08/31/2006 | WO2006090272A1 Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia |
| 08/31/2006 | WO2006090236A1 Preparation of high purity substituted quinoxaline |
| 08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | WO2006090169A1 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors |
| 08/31/2006 | WO2006089815A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | WO2006023852A3 Modulators of muscarinic receptors |
| 08/31/2006 | WO2005111038A3 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194972 Process for the production of imidazopyridin-8-ones |
| 08/31/2006 | US20060194968 Cyclic benizimidazoles |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194841 Benzylamine derivative |
| 08/31/2006 | US20060194833 Crystalline 1H-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 08/31/2006 | US20060194832 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 08/31/2006 | US20060194830 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 08/31/2006 | US20060194828 Vitamin comprising pyroloquinoline quinone and use thereof |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194785 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 08/31/2006 | US20060194782 Pharmacologically active imidazo[4,5-c] pyridines |
| 08/31/2006 | CA2599458A1 Process of purifying tadalafil |
| 08/31/2006 | CA2599378A1 Tadalafil having a large particle size and a process for preparation thereof |
| 08/31/2006 | CA2599212A1 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors |
| 08/31/2006 | CA2599124A1 Imidazo (1,2-a) pyridine compounds as vegf-r2 inhibitors |
| 08/31/2006 | CA2598853A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | CA2598656A1 Hydroxyalkyl substituted imidazoquinoline compounds and methods |
| 08/31/2006 | CA2598639A1 Hydroxyalkyl substituted imidazonaphthyridines |
| 08/31/2006 | CA2598533A1 Preparation of high purity substituted quinoxaline |
| 08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | CA2598327A1 Ocaperidone salts and pharmaceutical compositions containing the same |
| 08/31/2006 | CA2598133A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/31/2006 | CA2596667A1 Process of synthesizing tadalafil |
| 08/31/2006 | CA2593750A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 08/31/2006 | CA2586080A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/30/2006 | EP1695975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695973A1 Ocaperidone salt and pharmaceutical compositions containing the same |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |
| 08/30/2006 | EP1695960A1 Near-infrared fluorescent contrast medium |
| 08/30/2006 | EP1694686A1 Kinase inhibitors |
| 08/30/2006 | EP1694677A1 Spiropiperidine derivatives for controlling pests |
| 08/30/2006 | EP1694676A1 Spiroindoline derivatives having insecticidal properties |
| 08/30/2006 | EP1694675A2 Hydronopol derivatives as agonists on human orli receptors |
| 08/30/2006 | EP1694674A2 Sulfone substituted imidazo ring ethers |
| 08/30/2006 | EP1694672A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1603907B1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors |
| 08/30/2006 | EP1543002B1 Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates |
| 08/30/2006 | EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 08/30/2006 | EP1487450A4 Process for the preparation of antiviral 7-azaindole derivatives |
| 08/30/2006 | EP1436292B1 5-methoxy-8-aryl-¬1,2,4|triazolo¬1,5-a|pyridine derivatives as adenosine receptor antagonists |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof |
| 08/30/2006 | CN1826341A Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi |
| 08/30/2006 | CN1826340A Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use |
| 08/30/2006 | CN1824665A Aryl heterocyclic imidazole naphthaimide kind compound and its application |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098332 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098237 administering type II sPLA2 inhibitor such as 2-[[3-(2-amino-2-oxoethyl)-2-ethyl-1-(1-naphthyl)methylene-1H-indene-4-yl]oxy]acetic acid |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098221 Immune response modifiers; cytokine biosynthesis; viral and neoplastic diseases; n-(4-(4-amino-6,7-dimethyl-1h-imidazo (4,5-c)pyridin-1-yl)butyl)benzamide |
| 08/29/2006 | US7098220 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7097826 Conjugates of ditetratriethylamine pentacarboxylic acid (DTPA) and bisaminoethanethiol (N2S2); for magnetic resonance (MR) imaging; for tumor visualization and necrosis |
| 08/29/2006 | CA2158746C Process for preparing 6-fluoro-2-haloquinoline |
| 08/24/2006 | WO2006088949A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | WO2006088173A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity |
| 08/24/2006 | WO2006088028A1 Method for producing 2-azaindolizine, method for producing 2-azaindolizine metal complex, and 2-azaindolizine metal complex |
| 08/24/2006 | WO2006087538A1 Chemical compounds |
| 08/24/2006 | WO2006087306A2 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors |
| 08/24/2006 | WO2006087229A1 Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders |
| 08/24/2006 | WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 08/24/2006 | WO2006076598A3 Bicyclic heterocycles as cannabinoid receptor modulators |
| 08/24/2006 | WO2006065853A3 Crystalline forms of a factor xa inhibitor |
| 08/24/2006 | WO2006044821A8 Crf receptor antagonists and methods relating thereto |
| 08/24/2006 | WO2006034113A3 Quinolone analogs as cell proliferation inhibitors |
| 08/24/2006 | WO2006026313A3 Cancer treatment method |
| 08/24/2006 | WO2006019955A3 Antiviral methods and compositions |
| 08/24/2006 | WO2006017822A3 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 08/24/2006 | US20060189808 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189668 Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK |